| Lexicon Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript Lexicon Pharmaceuticals, Inc. (LXRX)Q1 2010 Earnings Call TranscriptMay 10, 2010 11:00 am ETComplete Story » seekingalpha.com |
Latisse Faces Patent Challenge The FDA said a company is challenging Allergan's patent protection for the eyelash drug Latisse, looking to make a generic version. online.wsj.com |
Sebelius Tackles States' Health-Overhaul Worries The secretary of health and human services is trying to appease cash-strapped governors who will have big sway over the success of the health overhaul passed in March. online.wsj.com |
InSight Imaging Reports Results for the Fourth Quarter and Fiscal Year Ended June 30, 2010 [Business Wire] - LAKE FOREST, Calif.----InSight Health Services Holdings Corp. today announced its financial results for the fourth quarter and fiscal year ended June 30, 2010. us.rd.yahoo.com |
FDA Approves Allergan's Botox to Prevent Migraines Allergan said the FDA widened the approved usage of its top product, Botox, to include the treatment of migraines. online.wsj.com |